ALENDRONATE SODIUM: Pharmaceutical manufacturers, suppliers, and wholesalers

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Hikma	ALENDRONATE SODIUM	alendronate sodium	SOLUTION;ORAL	090520	ANDA	Hikma Pharmaceuticals USA Inc.	0054-0282-59	4 BOTTLE, UNIT-DOSE in 1 CARTON (0054-0282-59) / 75 mL in 1 BOTTLE, UNIT-DOSE	2020-10-30
Novitium Pharma	ALENDRONATE SODIUM	alendronate sodium	SOLUTION;ORAL	214512	ANDA	ANI Pharmaceuticals, Inc.	70954-264-10	4 BOTTLE in 1 CARTON (70954-264-10) / 75 mL in 1 BOTTLE	2023-05-24
Aurobindo Pharma	ALENDRONATE SODIUM	alendronate sodium	TABLET;ORAL	090124	ANDA	NorthStar Rx LLC	16714-631-01	30 TABLET in 1 BOTTLE (16714-631-01)	2008-08-04
Aurobindo Pharma	ALENDRONATE SODIUM	alendronate sodium	TABLET;ORAL	090124	ANDA	NorthStar Rx LLC	16714-631-02	100 TABLET in 1 BOTTLE (16714-631-02)	2008-08-04
Aurobindo Pharma	ALENDRONATE SODIUM	alendronate sodium	TABLET;ORAL	090124	ANDA	NorthStar Rx LLC	16714-631-11	10 BLISTER PACK in 1 CARTON (16714-631-11) / 10 TABLET in 1 BLISTER PACK (16714-631-10)	2008-08-04
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: July 28, 2025

Introduction

Alendronate sodium is a bisphosphonate widely prescribed for the treatment and prevention of osteoporosis and other bone-related conditions. Its global demand has increased significantly due to rising awareness of osteoporosis and related skeletal health issues. As a critical therapeutic agent, ensuring a reliable supply chain of high-quality alendronate sodium is essential for pharmaceutical manufacturers, healthcare providers, and patients. This report explores the key suppliers, their manufacturing capabilities, regional presence, quality standards, and market dynamics influencing the supply landscape of alendronate sodium.

Overview of Alendronate Sodium

Alendronate sodium (C4H13NNaO7P2) is marketed primarily under brand names such as Fosamax, along with numerous generic equivalents. The drug functions by inhibiting osteoclast-mediated bone resorption, thereby increasing bone density. Regulatory agencies like the FDA and EMA demand stringent quality standards, including Good Manufacturing Practices (GMP), to ensure safety and efficacy.

Key Global Suppliers of Alendronate Sodium

1. Global Pharmaceutical Ingredient Manufacturers

The production of alendronate sodium involves complex chemical synthesis and purification processes, making manufacturing expertise a key criterion for suppliers. Several multinational and domestic companies dominate the supply chain, primarily focused in regions with robust pharmaceutical manufacturing ecosystems.

2. Leading Suppliers in the Market

a. Zhejiang Yuming Pharmatech Co., Ltd. (China)

Zhejiang Yuming Pharmatech is a China-based manufacturer with extensive experience in producing bisphosphonates. The company complies with GMP standards and supplies alendronate sodium bulk powder globally. They have a reputation for cost-effective production, meeting international quality benchmarks.

b. Wockhardt Ltd. (India)

Wockhardt is one of India's leading pharmaceutical companies, with manufacturing capabilities in active pharmaceutical ingredients (APIs). Their facility for alendronate sodium adheres to WHO-GMP standards, and Wockhardt exports to markets across Asia, Africa, and Latin America.

c. Teva Pharmaceutical Industries Ltd. (Israel)

As a global generics leader, Teva manufactures several bisphosphonates, including alendronate sodium. Their robust R&D infrastructure and high-quality manufacturing processes make them a reliable supplier, particularly for North American and European markets.

d. Jiangsu Hengrui Medicine Co., Ltd. (China)

Jiangsu Hengrui has expanded its portfolio to include bone resorption inhibitors like alendronate sodium, with certifications from major regulatory agencies. Their large-scale manufacturing capacity ensures consistent supply to global markets.

e. Zhejiang Huahai Pharmaceutical Co., Ltd. (China)

Huahai Pharmaceutical is a prominent Chinese API manufacturer, known for high-volume synthesis of bisphosphonates, including alendronate sodium, meeting international standards.

3. Domestic and Regional Suppliers

Several regional manufacturers cater to local markets, providing cost-competitive options, especially in developing countries. These suppliers often possess Good Manufacturing Practices (GMP) certifications and serve as critical access points for generic drug manufacturing.

Manufacturing Standards and Quality Assurance

Suppliers must meet international regulatory requirements, including:

GMP compliance enforced by agencies such as the FDA, EMA, or equivalent local authorities.
ISO certifications, notably ISO 9001 for quality management systems.
Environmental standards for waste management and chemical handling.
Extensive purification processes to eliminate impurities like other bisphosphonate analogs or residual solvents.

Adherence to these standards ensures sustained product quality, safety, and regulatory approval in various markets.

Market Dynamics Influencing Supplier Viability

Demand Dynamics

The global prevalence of osteoporosis is rising, especially in aging populations, increasing the demand for alendronate sodium. This drives manufacturers to expand capacities and optimize supply chains.

Regulatory Environment

Stringent regulations across markets necessitate continuous compliance efforts. Suppliers with extensive certification portfolios and proven track records of regulatory adherence maintain competitive advantage.

Raw Material Supply and Cost Factors

Alendronate sodium production depends on raw materials such as phosphorous compounds and amino acids, which can be affected by geopolitical factors and supply chain disruptions. Suppliers who have diversified sourcing strategies are better positioned to maintain supply continuity.

Generic Competition

Patents for alendronate sodium have expired or are close to expiration in major markets, leading to increased generic competition. This amplifies the importance of suppliers' cost competitiveness and manufacturing efficiency.

Strategic Alliances and Partnerships

Collaborations between API manufacturers and large pharmaceutical companies enhance market reach, quality assurance, and long-term supply security.

Regional Considerations

Asia-Pacific: Dominates the market in manufacturing capacity, with China and India as primary hubs, due to lower production costs and large-scale facilities.
Europe and North America: Focus on high-quality manufacturing with strict regulatory oversight; suppliers here often cater to premium markets.
Emerging Markets: Local suppliers provide affordable options, but quality assurance varies; import reliance is higher in these regions.

Future Outlook

The supply landscape of alendronate sodium is expected to remain competitive, driven by expanding demand and manufacturing investments in Asia. Regulatory harmonization, technological advancements in synthesis methods, and quality improvements will influence supplier dynamics. Key players are likely to invest in capacity expansion, process optimization, and strategic alliances to secure their market positions.

Key Challenges for Suppliers

Maintaining consistent high purity levels amid complex synthesis processes.
Navigating evolving regulatory requirements across different jurisdictions.
Securing and managing raw material supplies amid geopolitical or environmental constraints.
Managing pricing pressures from generic competitors.

Conclusion

The supply of alendronate sodium hinges on a network of established manufacturers predominantly in China, India, and Israel, supplemented by regional suppliers globally. Ensuring a reliable, high-quality supply chain requires adherence to international standards, strategic capacity investments, and resilient sourcing strategies. Stakeholders must monitor market trends, regulatory changes, and raw material markets to mitigate risks and capitalize on growth opportunities.

Key Takeaways

Leading suppliers for alendronate sodium include Zhejiang Yuming Pharmatech, Wockhardt, Teva, Jiangsu Hengrui, and Zhejiang Huahai, primarily based in Asia but with significant global presence.
Quality assurance through GMP compliance and regulatory certifications remains a critical differentiator among suppliers.
The expanding global demand driven by aging populations underscores the importance of capacity expansion and supply chain resilience.
Chinese and Indian manufacturers dominate the market, offering cost-effective options but require rigorous quality oversight.
Strategic partnerships, technological innovations, and regulatory compliance will shape the competitive landscape in the coming years.

FAQs

What are the primary regions producing alendronate sodium?
China and India are the leading regions manufacturing alendronate sodium, leveraging large-scale facilities and cost advantages. Israel also hosts key multinational manufacturers like Teva.
How do quality standards impact alendronate sodium suppliers?
Suppliers adhering to GMP, ISO certifications, and regulatory standards ensure product safety and efficacy, influencing market access and customer trust.
Is there a significant difference between branded and generic alendronate sodium suppliers?
Branded suppliers often emphasize extensive R&D and brand reputation, while generics focus on cost competitiveness and regulatory compliance to compete effectively.
What challenges do suppliers face in maintaining a steady supply of alendronate sodium?
Challenges include raw material sourcing, regulatory hurdles, production complexity, and price pressures from generic competitors.
What future trends will influence the supplier landscape for alendronate sodium?
Advances in synthesis technology, regulatory harmonization, capacity expansion in Asia, and increasing global demand will shape future supplier strategies.

References

[1] U.S. Food and Drug Administration (FDA). (2022). Drug Approvals and Market Data.
[2] European Medicines Agency (EMA). (2022). Regulatory Standards for Pharmaceuticals.
[3] MarketWatch. (2023). Pharmaceutical Active Ingredient Market Trends.
[4] Global Market Insights. (2023). Bisphosphonates Market Analysis.
[5] International Pharmaceutical Association. (2022). Good Manufacturing Practices (GMP) Overview.

Suppliers and packagers for ALENDRONATE SODIUM